机译:高血压和左心室肥大患者脉冲压力与新出售心房颤动的关联:延髓研究中延髓研究的氯沙坦干预
Department of Cardiology Oslo University Hospital Ullev?l Institute of Clinical Medicine;
Department of Cardiology Oslo University Hospital Ullev?l Institute of Clinical Medicine;
Department of Endocrinology Odense University Hospital Odense Denmark Research Focus Area for;
Division of Cardiology Holb?k Hospital Holb?k Denmark;
Greenberg Division of Cardiology Weill Cornell Medical College New York NY United States;
Greenberg Division of Cardiology Weill Cornell Medical College New York NY United States;
Department of Medicine Sahlgrenska University Hospital/?stra G?teborg Sweden;
Greenberg Division of Cardiology Weill Cornell Medical College New York NY United States;
Department of Cardiology Gentofte University Hospital Hellerup Denmark;
arrhythmia; atenolol; blood pressure; hypertension; losartan; structural heart disease;
机译:高血压和左心室肥大患者脉冲压力与新出售心房颤动的关联:延髓研究中延髓研究的氯沙坦干预
机译:在高血压和左心室肥厚患者中,以氯沙坦为基础的治疗的成本效益:基于氯沙坦的高血压终点降低干预(LIFE)研究的英国经济评估。
机译:高血压合并心电图检查的左心室肥厚患者的左心室壁应力和壁应力质量心率乘积:LIFE研究。氯沙坦干预用于降低高血压。
机译:基于ICG特征的基于截止的时频分析,用于高血压患者左心室肥大风险的评估
机译:动态血压监测仪对左心室肥厚与高血压阶段的关系。
机译:降压对高血压患者左室肥厚的影响:收缩压干预(SPRINT)试验
机译:高血压和左心室肥厚患者的脉压与新发房颤的相关性:高血压的氯沙坦干预终点(LIFE)降低研究